相关实验视频

Updated: Sep 8, 2025

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

综合多基因分析揭示了儿童B细胞急性淋巴细胞白血病的新型特异性调节相互作用

Irina Pushel^1,2, Zachary S Clark³, Lisa A Lansdon^2,4

¹Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO, USA.

bioRxiv : the preprint server for biology

|August 20, 2025

概括

这项研究整合了小儿B细胞急性淋巴细胞白血病 (B-ALL) 亚型的蛋白质组和转录组数据. 它确定了新的生物标志物,并建议信号作为Ph类B-ALL的治疗点.

科学领域:

癌症学
分子生物学
生物化学

背景情况:

儿童B细胞急性淋巴细胞白血病 (B-ALL) 的分子亚型改善了患者的结果.
尽管蛋白质是治疗点,但蛋白质分析尚未得到充分的研究.

研究的目的:

描述儿科B-ALL亚型的蛋白质和蛋白质格局.
通过多组组合识别新的亚型特异性生物标志物.
探索潜在的治疗途径,如信号在PH型B-ALL中.

主要方法:

转录组,蛋白组和蛋白组数据的多组集成.
从儿科B-ALL亚型:Ph-like (BCR::ABL1-like) 和ETV6::RUNX1的样本进行分析.
用于蛋白质和蛋白质分析的质谱学.

主要成果:

总结了B-ALL亚型的已知转录学发现.
鉴定出新的亚型特异性蛋白质和蛋白质生物标志物.
在类B-ALL中发现依赖信号的潜在作用.

结论:

多组组合增强了对B-ALL病变的理解.
新的生物标志物和信号通道为向治疗提供了潜力.
这种方法提升了儿童白血病治疗选择的精准医学.

更多相关视频

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...